Source of new products for the pharmaceutical industry
ABOUT DEVONIAN
Message from the president
“At Devonian Health Group Inc., our mission is to drive scientific advancement through pioneering innovation. We develop prescription therapeutic solutions grounded in rigorous science to address unmet medical needs and deliver sustainable value for all stakeholders. Our foundation rests on integrity, performance, and collaboration—values that shape how we operate and the partnerships we build. As we continue to expand our pipeline and global presence, our focus remains clear: to deliver meaningful innovations that enhance patient outcomes, strengthen our competitive position, and foster long-term growth for our investors and partners.’’
— Dr. André P. Boulet, PhD, Chairman & CEO
A clinical stage
pharmaceutical company
Focused on inflammatory diseases
Targeted therapies
Devonian Health Group Inc. develops prescription drugs that target multiple cellular pathways and regulate genes linked to fibroinflammatory autoimmune diseases, with a focus on gastrointestinal, dermatological, and hepatologic conditions.
Technology
Based on a broad-based platform originating from over 20 years of research.
Products
Novel therapeutics for fribroinflammatory diseases/autoimmune diseases.
Pipeline
Advanced stage products.
Investors
Focused on generating shareholder value.